Clinical Trial Update: Semaglutide for Alcohol Use Disorder [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating semaglutide for Alcohol Use Disorder has completed and posted results as of March 24, 2025; the study also enrolled participants who sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Tobacco Use Disorder

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Alcohol Use Disorder, Cigarette Smoking | Phase 2 | Status: COMPLETED | Results posted: 2025-03-24